Minimally invasive versus open surgery among colorectal cancer patients.

Minimally Invasive Surgery has become an acceptable substitute for Open Surgery in the management of colorectal cancer, with the claimed benefits of reduced morbidity and quicker recovery. Therefore it is of interest to compare the clinical and oncological results of MIS and OS among 200 patients with colorectal cancer over five years. The patients were evaluated for operative time, complications, hospital stay and disease-free survival. MIS has been demonstrated to be linked to markedly reduced stays in hospital (6 vs. 10 days) and decreased complication rates (15% vs. 25%) versus Open Surgery with similar oncologic outcomes: clearance of margins, as well as five-year disease- free survival, p > 0.05. Thus, data support MIS as an effective and safe method within suitably chosen patients with cancer of the colon and rectum, with advantage at recovery duration and complications.